These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4356456)

  • 1. Suppression of herpes simplex virus infection by phosphonoacetic acid.
    Shipkowitz NL; Bower RR; Appell RN; Nordeen CW; Overby LR; Roderick WR; Schleicher JB; Von Esch AM
    Appl Microbiol; 1973 Sep; 26(3):264-7. PubMed ID: 4356456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphonoacetic acid in the treatment of experimental ocular herpes simplex infections.
    Meyer RF; Varnell ED; Kaufman HE
    Antimicrob Agents Chemother; 1976 Feb; 9(2):308-11. PubMed ID: 1267429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.
    Wohlenberg CR; Walz MA; Notkins AL
    Infect Immun; 1976 May; 13(5):1519-21. PubMed ID: 178609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.
    Gerstein DD; Dawson CR; O JO
    Antimicrob Agents Chemother; 1975 Mar; 7(3):285-8. PubMed ID: 1137379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
    Alenius S; Laurent U; Oberg B
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE; Fondak AA; Buimovici-Klein E
    Infect Immun; 1977 Jun; 16(3):842-8. PubMed ID: 197008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.
    Gordon YJ; Lahav M; Photiou S; Becker Y
    Br J Ophthalmol; 1977 Aug; 61(8):506-9. PubMed ID: 199232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
    Fitzwilliam JF; Griffith JF
    J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disodium phosphonoacetate in cream base as a possible topical treatment for skin lesions of herpes simplex virus in cebus monkeys.
    Palmer AE; London WT; Sever JL
    Antimicrob Agents Chemother; 1977 Oct; 12(4):510-2. PubMed ID: 411417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose analogues in the chemotherapy of herpesvirus infections.
    Blough HA; Ray EK
    Pharmacol Ther; 1980; 10(3):669-81. PubMed ID: 6255498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapeutic activity of bonafton in experimental herpetic keratitis in rabbits].
    Bogdanova NS; Nikolaeva IS; Pershin GN
    Farmakol Toksikol; 1975; 38(6):728-32. PubMed ID: 1227924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):289-93. PubMed ID: 166611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
    Klein RJ; Friedman-Kien AE; Yellin PB
    Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice.
    Allen LB; Hintz OJ; Wolf SM; Huffman JH; Simon LN; Robins RK; Sidwell RW
    J Infect Dis; 1976 Jun; 133 Suppl():A178-83. PubMed ID: 6598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid.
    Herrin TR; Fairgrieve JS; Bower RR; Shipkowitz NL
    J Med Chem; 1977 May; 20(5):660-3. PubMed ID: 853505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of antiherpetic drugs in animal experiments.
    Streissle G
    Adv Ophthalmol; 1979; 38():43-8. PubMed ID: 525527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.